TuHURA Biosciences (HURA) Other Non Operating Income (2012 - 2026)
TuHURA Biosciences' (HURA) quarterly Other Non Operating Income came in at -$6699.0 in Q1 2026, down 101.9% year-on-year from $352652.0 in Q1 2025, and down 100.47% quarter-over-quarter from $1.4 million in Q4 2025.
TuHURA Biosciences (HURA) Other Non Operating Income (2012 - 2026) Analysis & Trends
TuHURA Biosciences' Other Non Operating Income history runs 15 years deep, the most recent figure standing at -$6699.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 101.9% year-over-year to -$6699.0 in Q1 2026; TTM through Mar 2026 was $1.4 million, a 125.18% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 143.24% from the prior year.
- Other Non Operating Income slipped to -$6699.0 in Q1 2026 per HURA's latest filing, from $1.4 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.4 million in Q4 2025 and bottomed at -$3.7 million in Q3 2024.
- The 5-year median for Other Non Operating Income is -$1500.0 (2023), against an average of -$293486.6.
- Across the five-year window, Other Non Operating Income plunged 186489.45% in 2024 and jumped 249.18% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at $11000.0 in 2022, then slumped by 172.73% to -$8000.0 in 2023, then tumbled by 46547.36% to -$3.7 million in 2024, then soared by 137.84% to $1.4 million in 2025, then slumped by 100.47% to -$6699.0 in 2026.
- Per Business Quant, the three latest HURA Other Non Operating Income figures stand at -$6699.0 (Q1 2026), $1.4 million (Q4 2025), and -$372852.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,699.00 |
| Dec 31, 2025 | 1.41 Mn |
| Sep 30, 2025 | -372,852.00 |
| Jun 30, 2025 | 352,121.00 |
| Mar 31, 2025 | 352,652.00 |
| Sep 30, 2024 | -3.73 Mn |
| Jun 30, 2024 | -1.88 Mn |
| Mar 31, 2024 | -236,388.00 |
| Dec 31, 2023 | -8,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Sep 30, 2022 | 11,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | -9,000.00 |
| Mar 31, 2021 | -1,000.00 |
| Dec 31, 2020 | -3,000.00 |
| Sep 30, 2020 | 1,000.00 |